Health Care and the Race to Leave America

On Monday's MarketFoolery, host Chris Hill, along with Motley Fool One analyst Jason Moser and Stock Advisor Canada's Taylor Muckerman, discuss the biggest market news of the day, as Medtronic (NYSE: MDT  ) is set to buy Covidien (NYSE: COV  ) and move to Ireland.

Medtronic, the medical-device-maker giant, will be buying Covidien for about $43 billion. But Chris notes that the news doesn't stop there, with Medtronic moving its operations across the Atlantic. Jason says the minuscule tax rates in Ireland make the country look quite favorable for companies, and he likes this deal for a variety of reasons, with taxes possibly being No. 1, as the move to Ireland would stick it to the higher American tax rates, which Chris notes can range from 15% to 30%. The deal, Chris and Jason say, will offer investors a nice buyout deal. Moreover, the long-term implications of the acquisition should make Medtronic's investors happy. Taylor says the deal will give Medtronic a lot of negotiating power and could result in more favorable pricing and more Medtronic devices in hospitals. 

Chris wonders about the political ramifications of companies that move to other countries. Although Medtronic isn't a household name, if Pfizer  (NYSE: PFE  ) had made this play to find the best taxes, would the government take notice? Jason and Taylor also talk about companies such as lululemon athletica (NASDAQ: LULU  ) and eBay  (NASDAQ: EBAY  ) and tax holidays. 

Leaked: This coming blockbuster will make every biotech jealous
The best biotech investors consistently reap gigantic profits by recognizing true potential earlier and more accurately than anyone else. To that end, there is a product in development that will change how we treat a common chronic illness and also potentially revolutionize the entire health industry. Analysts are already licking their chops at the sales potential. To outsmart Wall Street and realize multibagger returns, you need The Motley Fool's new free report on the dream team responsible for this game-changing blockbuster. Click here now.

Read/Post Comments (0) | Recommend This Article (1)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2996446, ~/Articles/ArticleHandler.aspx, 9/2/2015 12:30:58 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Chris Hill

Full-time host of the Motley Fool Money radio show, MarketFoolery podcast, and other things. Part-time connoisseur of movies, basketball & fine bourbon.

Today's Market

updated 3 hours ago Sponsored by:
DOW 16,058.35 -469.68 -2.84%
S&P 500 1,913.85 -58.33 -2.96%
NASD 4,636.11 -140.40 -2.94%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

12/31/1969 7:00 PM
COV $0.00 Down +0.00 +0.00%
Covidien CAPS Rating: *****
EBAY $26.48 Down -0.63 -2.32%
eBay CAPS Rating: ****
LULU $63.07 Down -0.94 -1.47%
Lululemon Athletic… CAPS Rating: ***
MDT $69.53 Down -2.76 -3.82%
Medtronic CAPS Rating: ****
PFE $31.36 Down -0.86 -2.67%
Pfizer CAPS Rating: ****